GCP Research

St. Petersburg, Florida 33705

3 studies enrolling now · 13 studies all time

What they study most

Atopic Dermatitis, Celiac Disease, Cystic Fibrosis, Depression, Postpartum, Fluid Balance, Focal Segmental Glomerulosclerosis (FSGS), Hepatic Impairment, Idiopathic Gastroparesis, Pain, Pharmacokinetics, Plaque Psoriasis, Post-Natal Depression

Studies at this site

• VTP-1000 in Adults With Celiac Disease — Recruiting now
• Assessment of Quizartinib Pharmacokinetic in Subjects With Severe Hepatic Impairment — Recruiting now
• Effects of Beverage Volume, Glycerol Concentration, and Sodium Concentration on Fluid Balance in Healthy Euhydrated Men and Women at Rest — Recruiting now
• A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression — Completed
• A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis. — Completed
• Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis — Completed
• A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) — Stopped early
• Evaluation of the Pharmacokinetics and Safety of Inaxaplin in Participants With Mild or Moderate Hepatic Impairment — Completed
• Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD) — Running, not enrolling
• Assessment of KAN-101 in Celiac Disease (ACeD) — Completed
• Evaluation of the Pharmacokinetics and Safety of VX-548 in Participants With Renal Impairment — Completed
• Pharmacokinetics and Safety Assessment of VX-121/Tezacaftor/Deutivacaftor in Participants With Moderate Hepatic Impairment — Completed
• Pilot Study Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage in the Fed and Fasted States — Completed